off label use of semaglutide Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes Prescription of diabetes drug Ozempic

Zhong Y, Cai D, Cai W, Geng S, Chen L, Han T: Protective effect of galactooligosaccharide-supplemented enteral nutrition on intestinal barrier function in rats with severe acute pancreatitis

Differential diagnosis of coma or sedation of unknown origin (to check if benzodiazepine involvement exists) --- Dosage (Adults): Initial dose: 0.2 mg IV over 15 seconds If no response, give 0.3 mg after 30 seconds May repeat 0.5 mg every 30 seconds up to a total of 3 mg (occasionally 5 mg if needed) --- Side Effects: Nausea and vomiting Dizziness Agitation or anxiety Headache Seizures (especially in patients dependent on benzodiazepines or co-ingesting tricyclic antidepressants) Arrhythmias (rare) --- Contraindications: Hypersensitivity to flumazenil Chronic benzodiazepine users (can trigger withdrawal and seizures) Patients with seizure disorders treated with benzodiazepines Mixed drug overdose (especially tricyclic antidepressants) --- Precautions: Continuous monitoring required for respiration and consciousness Risk of re-sedation after initial reversal due to flumazenils short half-life Use cautiously in hepatic impairment --- Storage: Store below 25C, protected from light

Additionally, the body must rely on liver detoxification to get rid of it

For patients who prefer tablets over injections, oral Semaglutide offers a more convenient option

References Torbahn G, Brauchmann J, Axon E, et al

Female-specific research remains limited relative to the broader literature on IGF-1 LR3